Position in BCYC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$121,382
-$11,842 QoQ
Shares Held
26,160
+39.0% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BCYC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Aquatic Capital Management LLC holds $123,092,373 across 91 Biotechnology names. BCYC ranks #77 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
147,379 | $11,066,689 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
31,061 | $10,277,153 | |
| 3 | EXEL |
Exelixis, Inc.
|
194,571 | $8,345,150 | |
| 4 | RPRX |
Royalty Pharma plc
|
127,227 | $6,103,079 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
80,227 | $5,030,232 | |
| 6 | CYTK |
Cytokinetics Inc
|
72,478 | $4,777,024 | |
| 7 | XENE |
Xenon Pharmaceuticals Inc.
|
79,199 | $4,605,421 | |
| 8 | NKTR |
Nektar Therapeutics
|
57,014 | $4,102,157 |
All Filings in BCYC
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $121,382 | 26,160 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $133,224 | 18,817 | Shares | Sole | 2026-02-17 | |
| 2024-06-30 | $111,320 | 5,500 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $81,360 | 4,500 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $18,081 | 900 | Shares | Sole | 2023-11-14 | |
| 2023-03-31 | $17,016 | 800 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||